Bioceptive, Inc. — Form D

Bioceptive, Inc. of NEW ORLEANS, LA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-30. The offering totals $1.5M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

Filed: 2013-12-30
Form: D
Accession: 0001527900-13-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.5M
Amount sold: $1.3M
Remaining: $250K
Investors: 12
Date of first sale: 2013-12-20
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-208896

Issuer

Name: Bioceptive, Inc.
CIK: 0001527900
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2011
Address: NEW ORLEANS BIOINNOVATION CENTER, NEW ORLEANS, LA, 70112
Phone: (504) 598-5233

Officers, directors & promoters (12)

Name	Role	Location
TOM BALDERSTON	Director	Atlanta, GA
Stewart Davis	Director	New Orleans, LA
Stewart Davis	Executive Officer	New Orleans, LA
Shuchi Khurana	Executive Officer	New Orleans, LA
Benjamin Cappiello	Director	New Orleans, LA
Benjamin Cappiello	Executive Officer	New Orleans, LA
Joan Neuscheler	Director	New Orleans, LA
Joseph Kumar Lovett	Director	Baton Rouge, LA
Amit Kumar Rathi	Director	Bangalore, K7
Orin Levy	Director	Boca Raton, FL
Shuchi Kumar Khurana	Executive Officer	New Orleans, LA
John Hardman	Director	Atlanta, GA

Other filings by this issuer (6)

Filed	Form	Offering	Sold
2016-01-29	D	$650K	$416K
2013-03-01	D/A	$1.1M	$1.1M
2012-10-24	D	$1.0M	—
2012-03-26	D	$200K	$40K
2012-03-26	D/A	$250K	$40K
2011-08-15	D	$135K	$135K

More